Pre-, peri-, and postoperative management of chronic subdural hematomain and the role of antithrombotic and oral anticoagulant treatment on the development of recurrence and thromboembolic events, a retrospective study

• Conditions: I62.02; I74.9; Embolism and thrombosis of unspecified artery

• Registration Number: DRKS00025280
• Lead Sponsor: niversitätsklinikum der RWTH Aachen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-12-31
• Study Start: 2021-06-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 408

Inclusion Criteria

Chronic subdural hematomas as confirmed on CT imaging (uni- or bilateral) treated by surgical evacuations either via twist drill craniostomy (TDC), single or double burr hole craniostomy (BHC) or bone flap craniotomy (BFC).

Exclusion Criteria

Patients < 18 years of age, prior causal neurosurgical or other potentially causal cranial procedures, causal intracranial hypotension i.e. shunt overdrainage and spinal dural leaks,
acute subdural hematoma with a minor chronic components suggesting an acute hemorrhaging of chronic subdural hematoma membranes as the culprit.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Predictors of recurrence of chronic subdural hematoma.

Secondary Outcome Measures

Name	Time	Method
Effects of seizing blood thining medication on the occurence of thromboembolic events around the treatment of chronic subdural hematomas. <br>The effects of the internal architecture of hematomas on their recurrence rate and clinical outcome. <br>The effects of pneumocephalus after surgical treatment of chronic subdural hematoma, on clinical outcome. <br>The effects of epileptic seizures after surgical treatment of chronic subdural hematoma, on clinical outcome.